Selective Oral Decontamination of the Esophagus to Reduce Microbial Burden in Patients Undergoing Esophagectomy for Esophageal Cancer (SODA)—First Results from a Proof-of-Principle Study

<b>Background/Objectives:</b> Postoperative pneumonia and other infectious complications after robotic-assisted minimally invasive esophagectomy still contribute to morbidity and mortality. Selective oral decontamination of the esophagus prior to surgery might reduce the rate of infectious complications. However, its impact on the esophageal microbiota is unknown. Therefore, this study aimed to analyze whether selective oral decontamination of the esophagus prior to surgery reduces postoperative pneumonia rates and alters the esophageal microbiome. <b>Methods:</b> We conducted a proof-of-principle study including 22 patients who underwent robotic-assisted minimally invasive esophagectomy. Thirteen patients were treated with 50 mg amphotericin B, 8 mg tobramycin, and 10 mg colistin orally 7 days prior to surgery, intraoperatively, and 5 days postoperatively. The remaining nine patients received standard-of-care treatment (no oral decontamination). The esophageal microbiome was assessed using 16S rRNA gene amplicon libraries which were annotated using the Ribosomal Data Project. The incidence of postoperative (at discharge from hospital or 30 days, whichever was later) infectious complications was assessed. <b>Results:</b> Selective oral decontamination was associated with reduced overall rates of infectious complications (7.7% vs. 55.5%, <i>p</i> = 0.008) and postoperative pneumonia (0% vs. 33.3%, <i>p</i> = 0.007). Alterations in the esophageal microbiome depending on selective oral decontamination were detectable. The microbiomes of patients with infectious complications showed higher abundances of <i>Neisseria</i> and lower abundances of <i>Streptococcus</i> than samples without infectious complications. <b>Conclusions:</b> Selective oral decontamination reduced the rate of postoperative complications, postoperative pneumonia in particular, after robot-assisted esophagectomy. Alterations in the microbiome were also evident following decontamination. Further studies with larger sample sizes are necessary to confirm these data.

Authors

Institutions

Publication Details

Journal
Antibiotics
Published
2025-10-15
DOI
https://doi.org/10.3390/antibiotics14101033
Citations
1
Primary Topic
Esophageal and GI Pathology
Type
article
Field-Weighted Citation Impact
2.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Selective Oral Decontamination of the Esophagus to Reduce Microbial Burden in Patients Undergoing Esophagectomy for Esophageal Cancer (SODA)—First Results from a Proof-of-Principle Study

Konrad Lehr, Ulrich Ronellenfitsch, Artur Rebelo, Alexander Link et al.
1 citations
Antibiotics
Esophageal and GI Pathology
2.01
article

Selective Oral Decontamination of the Esophagus to Reduce Microbial Burden in Patients Undergoing Esophagectomy for Esophageal Cancer (SODA)—First Results from a Proof-of-Principle Study

Konrad Lehr, Ulrich Ronellenfitsch, Artur Rebelo, Alexander Link, Jörg Kleeff, Michelle A. Klose, Johannes Klose, Daniel Ebert
article en
1 citations

Abstract

<b>Background/Objectives:</b> Postoperative pneumonia and other infectious complications after robotic-assisted minimally invasive esophagectomy still contribute to morbidity and mortality. Selective oral decontamination of the esophagus prior to surgery might reduce the rate of infectious complications. However, its impact on the esophageal microbiota is unknown. Therefore, this study aimed to analyze whether selective oral decontamination of the esophagus prior to surgery reduces postoperative pneumonia rates and alters the esophageal microbiome. <b>Methods:</b> We conducted a proof-of-principle study including 22 patients who underwent robotic-assisted minimally invasive esophagectomy. Thirteen patients were treated with 50 mg amphotericin B, 8 mg tobramycin, and 10 mg colistin orally 7 days prior to surgery, intraoperatively, and 5 days postoperatively. The remaining nine patients received standard-of-care treatment (no oral decontamination). The esophageal microbiome was assessed using 16S rRNA gene amplicon libraries which were annotated using the Ribosomal Data Project. The incidence of postoperative (at discharge from hospital or 30 days, whichever was later) infectious complications was assessed. <b>Results:</b> Selective oral decontamination was associated with reduced overall rates of infectious complications (7.7% vs. 55.5%, <i>p</i> = 0.008) and postoperative pneumonia (0% vs. 33.3%, <i>p</i> = 0.007). Alterations in the esophageal microbiome depending on selective oral decontamination were detectable. The microbiomes of patients with infectious complications showed higher abundances of <i>Neisseria</i> and lower abundances of <i>Streptococcus</i> than samples without infectious complications. <b>Conclusions:</b> Selective oral decontamination reduced the rate of postoperative complications, postoperative pneumonia in particular, after robot-assisted esophagectomy. Alterations in the microbiome were also evident following decontamination. Further studies with larger sample sizes are necessary to confirm these data.

AntibioticsVol. 14(10)
Bayreuth Medical Center (DE), Martin Luther University Halle-Wittenberg (DE), Otto-von-Guericke-Universität Magdeburg (DE)
Openalex Percentile: Top 11%
Esophageal and GI Pathology
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.